tiprankstipranks
William Blair pharmaceuticals analysts hold analyst/industry conference call
PremiumThe FlyWilliam Blair pharmaceuticals analysts hold analyst/industry conference call
11d ago
ZVRA Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
ZVRA Upcoming Earnings Report: What to Expect?
12d ago
Zevra Therapeutics, NUCDF launch check ammonia campaign
Premium
The Fly
Zevra Therapeutics, NUCDF launch check ammonia campaign
1M ago
Xoma notes FDA approval of Zevra’s MIPLYFFA in patients with NPC
PremiumThe FlyXoma notes FDA approval of Zevra’s MIPLYFFA in patients with NPC
2M ago
Zevra Therapeutics’ MIPLYFFA Wins FDA Approval for NPC
Premium
Company Announcements
Zevra Therapeutics’ MIPLYFFA Wins FDA Approval for NPC
2M ago
Zevra Therapeutics Inc trading resumes
Premium
The Fly
Zevra Therapeutics Inc trading resumes
2M ago
Zevra Therapeutics price target lowered to $22 from $24 at Canaccord
PremiumThe FlyZevra Therapeutics price target lowered to $22 from $24 at Canaccord
2M ago
Zevra Therapeutics presents data for arimoclomol, OLPRUVA at SSIEM 2024
Premium
The Fly
Zevra Therapeutics presents data for arimoclomol, OLPRUVA at SSIEM 2024
3M ago
Zevra Therapeutics reports Q2 EPS (48c), consensus (43c)
Premium
The Fly
Zevra Therapeutics reports Q2 EPS (48c), consensus (43c)
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100